IRulya Therapeutics Inc. (IRLA)
NASDAQ: IRLA · Real-Time Price · USD
40.59
+2.14 (5.57%)
At close: Nov 18, 2026, 4:00 PM EST
43.04
+2.45 (6.04%)
Pre-market: Nov 19, 2026, 7:48 AM EST
IRulya Therapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Leerink Partners | Leerink Partners | Buy Reiterates $68 | Buy | Reiterates | $68 | +67.53% | Nov 19, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $70 | Buy | Maintains | $70 | +72.46% | Nov 19, 2026 |
| Citizens JMP | Citizens JMP | Buy Maintains $77 → $86 | Buy | Maintains | $77 → $86 | +111.87% | Nov 16, 2026 |
| Raymond James | Raymond James | Buy Initiates $72 | Buy | Initiates | $72 | +77.38% | Oct 9, 2026 |
| LifeSci Capital | LifeSci Capital | Buy Maintains $98 | Buy | Maintains | $98 | +141.44% | Sep 30, 2026 |
| Craig-Hallum | Craig-Hallum | Buy Maintains $68 | Buy | Maintains | $68 | +67.53% | Sep 30, 2026 |
| Rodman & Renshaw | Rodman & Renshaw | Buy Initiates $70 | Buy | Initiates | $70 | +72.46% | Sep 24, 2026 |
| Oppenheimer | Oppenheimer | Buy Reiterates $82 | Buy | Reiterates | $82 | +102.02% | Aug 17, 2026 |